This study presents SynaptoGen, a differentiable extension of connectome models that links gene expression, protein-protein interaction probabilities, synaptic multiplicity, and synaptic weights, and ...
Gene Holdings Inc. rises on 62% CR rate in Phase 2 NMIBC trial. Click to learn about ENGN and its gene delivery tech, market ...
CCN1 is a key factor for stabilizing brain circuits in adulthood, offering a therapeutic target for conditions, such as Alzheimer's and PTSD.
Cambridge, USA-based CAMP4 Therapeutics has entered into a strategic research, collaboration and license agreement with UK ...
Agriculture, from the outset, has been made possible by humans tweaking the genes of plants to make them grow faster, produce ...
The agreement also allows both parties to incorporate products developed on Fermbox Bio’s microbial platforms into the joint portfolio.
The CancerVax platform is designed to harness the body’s existing immunity to detect, mark, and kill cancer cells with ...
Moleculin Biotech Inc. (NASDAQ:MBRX) shares fell 9.1% in premarket trading on Wednesday after the company disclosed results ...
Manufacture of multiple Dyadic-origin products by Fermbox Bio , enabling efficient production and market expansion of sustainable, animal-free proteins and enzymes. Dual-Sourcing flexibility, allowing ...
TipRanks on MSN
Biotech alert: Searches spiking for these stocks today
These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They include: ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results